Gallia G Levy

Gallia G Levy

UNVERIFIED PROFILE

Are you Gallia G Levy?   Register this Author

Register author
Gallia G Levy

Gallia G Levy

Publications by authors named "Gallia G Levy"

Are you Gallia G Levy?   Register this Author

14Publications

188Reads

6Profile Views

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.

N Engl J Med 2018 08;379(9):811-822

From the Haemophilia Comprehensive Care Centre, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg (J.M.); Universitätsklinikum Bonn, Bonn, Germany (J.O.); Genentech, South San Francisco, CA (I.P.-P., J.I.A., G.G.L.); Louis Pradel University Hospital, Lyon, France (C.N.); F. Hoffmann-La Roche, Basel, Switzerland (M.N., C.S., C.D., E.A.); Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan (M.E.M.); the Hematology Department, Hospital Universitario La Paz, Autónoma University, Madrid (V.J.-Y.); the Department of Hematology and Medical Oncology, Emory School of Medicine, Atlanta (C.K.); Children's Hospital of Michigan, Detroit (M.U.C.); Instituto Costarricense de Investigaciones Científicas, San José, Costa Rica (W.B.); the Department of Pediatrics, Nara Medical University, Kashihara, Japan (M.S.); and the Washington Center for Bleeding Disorders at Bloodworks Northwest, Seattle (R.K.-J.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1803550
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1803550DOI Listing
August 2018

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

N Engl J Med 2017 11;377(22):2194-2195

Genentech, South San Francisco, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1712683DOI Listing
November 2017

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

N Engl J Med 2017 08 10;377(9):809-818. Epub 2017 Jul 10.

From Universitätsklinikum Bonn, Bonn, Germany (J.O.); the Haemophilia Comprehensive Care Centre, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg (J.N.M.); Genentech, South San Francisco (B.K., N.V., G.G.L.), and Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles (G.Y.) - both in California; F. Hoffmann-La Roche, Basel, Switzerland (C.S., E.A.); Children's Hospital of Michigan, Detroit (M.U.C.); the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Foundation, Ospedale Maggiore Policlinico, Milan (E.S.); Bloodworks Northwest, Seattle (R.K.-J.); Louis Pradel Cardiology Hospital, University Claude Bernard, Lyon, France (C.N.); Georgetown University Medical Center, Washington, DC (C.K.); the Department of Disorders of Hemostasis and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland (J.W.); and the Department of Pediatrics, Nara Medical University, Kashihara, Japan (M.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1703068DOI Listing
August 2017

The endothelial-specific regulatory mutation, Mvwf1, is a common mouse founder allele.

Mamm Genome 2008 Jan 11;19(1):32-40. Epub 2008 Jan 11.

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, 48109-2216, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00335-007-9079-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2226002PMC
January 2008

Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene.

Blood 2006 Nov 27;108(9):3061-7. Epub 2006 Jul 27.

Howard Hughes Medical Institute, University of Michigan, 210 Washtenaw, Life Sciences Institute, Rm 5028, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-014688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895519PMC
November 2006

ADAMTS13 turns 3.

Blood 2005 Jul 17;106(1):11-7. Epub 2005 Mar 17.

Cell and Molecular Biology Program and Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-10-4097DOI Listing
July 2005

Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands.

Proc Natl Acad Sci U S A 2002 Jul 3;99(15):10042-7. Epub 2002 Jul 3.

Howard Hughes Medical Institute and Department of Cellular and Molecular Medicine, 9500 Gilman Drive 0625, University of California San Diego, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.142005099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC126621PMC
July 2002